Sotera Health (NASDAQ:SHC) Stock Price Down 6.5% – Should You Sell?

Sotera Health (NASDAQ:SHC) was down 6.5% on Tuesday . The stock traded as low as $14.22 and last traded at $14.77. Approximately 101,509 shares changed hands during mid-day trading, a decline of 92% from the average daily volume of 1,298,739 shares. The stock had previously closed at $15.80.

Analysts Set New Price Targets

A number of research firms have weighed in on SHC. Barclays lifted their target price on Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a report on Tuesday, August 6th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $17.00 target price on shares of Sotera Health in a report on Tuesday, August 6th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, Sotera Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $15.70.

Sotera Health Trading Down 2.8 %

The firm’s 50-day simple moving average is $15.95 and its 200-day simple moving average is $13.64. The firm has a market capitalization of $4.35 billion, a P/E ratio of 105.50 and a beta of 2.08. The company has a quick ratio of 2.59, a current ratio of 2.93 and a debt-to-equity ratio of 5.46.

Sotera Health (NASDAQ:SHC) last announced its earnings results on Monday, August 5th. The company reported $0.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.15 by $0.04. Sotera Health had a net margin of 3.65% and a return on equity of 47.26%. The company had revenue of $277.00 million during the quarter, compared to analyst estimates of $266.45 million. During the same period in the previous year, the business earned $0.19 earnings per share. The firm’s quarterly revenue was up 8.6% compared to the same quarter last year. Analysts anticipate that Sotera Health will post 0.64 EPS for the current year.

Insider Activity at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock in a transaction on Friday, September 6th. The shares were sold at an average price of $15.03, for a total value of $150,300,000.00. Following the transaction, the director now owns 49,215,301 shares in the company, valued at $739,705,974.03. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 55.12% of the stock is currently owned by insiders.

Institutional Trading of Sotera Health

Large investors have recently added to or reduced their stakes in the stock. Janus Henderson Group PLC lifted its position in Sotera Health by 43.6% during the first quarter. Janus Henderson Group PLC now owns 14,892,868 shares of the company’s stock valued at $178,865,000 after buying an additional 4,525,056 shares during the period. Vanguard Group Inc. raised its position in Sotera Health by 27.0% in the 1st quarter. Vanguard Group Inc. now owns 12,145,110 shares of the company’s stock worth $145,863,000 after buying an additional 2,579,248 shares during the last quarter. Darsana Capital Partners LP purchased a new position in shares of Sotera Health during the second quarter valued at approximately $29,074,000. Khrom Capital Management LLC purchased a new stake in Sotera Health during the 1st quarter valued at $14,626,000. Finally, AQR Capital Management LLC boosted its position in Sotera Health by 3,198.2% in the second quarter. AQR Capital Management LLC now owns 511,580 shares of the company’s stock worth $6,072,000 after purchasing an additional 496,069 shares during the last quarter. Institutional investors own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.